Mannheimia haemolytica (Newsom and Cross) Angen et al. (ATCC® 55518)

Strain Designations: NADC-D60aroA-  /  Type Strain: no  /  Biosafety Level: 2

Deposited As Pasteurella haemolytica Newsom and Cross
Strain Designations NADC-D60aroA-
Application
Used to produce live, attenuated veterinary vaccines against Pasteurella haemolytica
Isolation
Lung from cow with pneumonic pasteurellosis
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol® no
Type Strain no
Name of Depositor National Animal Disease Center, ARS, USDA
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Special Collection NCRR Contract
Isolation
Lung from cow with pneumonic pasteurellosis
References

Briggs RE, Tatum FM. Construction of Pasteurella haemolytica vaccines. US Patent 5,733,780 dated Mar 31 1998